ArticleLiver cancer2025

Reevaluating the Role of Demographic and Etiological Factors in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma.

Wenli Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.